Phase I study of camrelizumab in patients with advanced solid tumors.
Yuxiang MaJiaxin CaoYang ZhangQianwen LiuWenfeng FangYunpeng YangYuanyuan ZhaoQing YangHongyun ZhaoLi ZhangPublished in: Signal transduction and targeted therapy (2023)
Keyphrases